Market Cap 982.77M
Revenue (ttm) 0.00
Net Income (ttm) -244.17M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 986,005
Avg Vol 3,176,620
Day's Range N/A - N/A
Shares Out 269.99M
Stochastic %K 68%
Beta 2.17
Analysts Strong Sell
Price Target $8.57

Company Profile

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including type 1 diabetes, B cell mediated autoimmune diseases, and oncology. The company's product pipeline includes UP421, a HIP-modified allogeneic primary islet cell product, which is in phase 1 clinical trial to treat type 1 diabetes; SC451, a HIP-modifi...

Industry: Biotechnology
Sector: Healthcare
Phone: 206 701 7914
Address:
188 East Blaine Street, Suite 400, Seattle, United States
BriOnH
BriOnH May. 8 at 5:28 PM
$SANA Interview (video) with Steve Harr https://www.biopharminternational.com/view/stem-cell-derived-islet-therapies-target-type-1-diabetes-challenges
1 · Reply
Ornery
Ornery May. 8 at 3:36 PM
$SANA added another 1000 shares just because
0 · Reply
demarco4ever
demarco4ever May. 8 at 3:03 PM
$SANA I think we are at the new bottom ! Hopefully up from here
0 · Reply
MorganHoratio
MorganHoratio May. 8 at 1:44 PM
Google just released its updated 13F filing which shows all the stocks it owned as of the end of Q1: PayPay Corp (Tokyo-listed) - 3,125,000 $PL - 35,248,893 $PRME - 16,562,498 $RLAY - 1,564,173 $RVMD - 3,292,525 $SANA - 2,812,500 Google’s Q1 13F is here: Fintech, Real-time Earth, and Gene Editing! The 3.1M share stake in PayPay is a major power move into the East Asian payment ecosystem. Meanwhile, holding 35M shares of $PL (Planet Labs) signals that Google is weaponizing satellite data to give Gemini AI a "God’s eye view" of global logistics. Heavy bets on $PRME and $RVMD also prove that AI-driven oncology and gene editing are now core to Alphabet’s "Other Bets." Do you think the synergy between satellite data and fintech will lead to a breakthrough in 2026? Which of these strategic pivots are you most bullish on?
0 · Reply
LoveRetailFroth
LoveRetailFroth May. 8 at 1:11 PM
$AMLX Good Morning ☕️ $SMMT $SANA $RXRX
0 · Reply
BBraggHillBoys
BBraggHillBoys May. 7 at 9:53 PM
0 · Reply
LoveRetailFroth
LoveRetailFroth May. 7 at 12:55 PM
$SANA Perking up to Earnings Potential 10X☕️🚀
0 · Reply
LoveRetailFroth
LoveRetailFroth May. 7 at 12:51 PM
$SMMT Good Morning ☕️ Another $RVMD here. $AMLX $SANA $RXRX
0 · Reply
Love_To_Learn
Love_To_Learn May. 7 at 12:41 PM
$SANA $SLS $NA MOVING THE CHAINS
0 · Reply
OnlyInvestor
OnlyInvestor May. 7 at 6:45 AM
$SANA completely off topic but lots of diabetics in here. If you’re bored and day dreaming of cures, or thinking about your busted pancreas, Google “Human α-cell plasticity.” Some old medical journals about alpha cells spontaneously converting to beta cells (not enough to be effective) during autopsies of dead people. Crazy the things our bodies do to try and work around this BS
1 · Reply
Latest News on SANA
Sana Biotechnology files automatic mixed securities shelf

2026-03-03T22:25:38.000Z - 2 months ago

Sana Biotechnology files automatic mixed securities shelf


Sana Biotechnology reports Q4 EPS (16c), consensus (13c)

2026-03-03T21:25:24.000Z - 2 months ago

Sana Biotechnology reports Q4 EPS (16c), consensus (13c)


Sana Biotechnology to Present at March 2026 Investor Conferences

Feb 23, 2026, 4:05 PM EST - 2 months ago

Sana Biotechnology to Present at March 2026 Investor Conferences


Sana Biotechnology appoints Piper as EVP, CFO

2026-02-17T14:16:15.000Z - 2 months ago

Sana Biotechnology appoints Piper as EVP, CFO


Sana Biotechnology price target raised to $7 from $6 at BofA

2026-01-06T15:25:24.000Z - 4 months ago

Sana Biotechnology price target raised to $7 from $6 at BofA


Sana Biotechnology reports Q3 EPS (16c), consensus (19c)

2025-11-06T23:25:54.000Z - 6 months ago

Sana Biotechnology reports Q3 EPS (16c), consensus (19c)


Sana Biotechnology strength attributed to EMJ Capital long call

2025-10-15T17:45:20.000Z - 7 months ago

Sana Biotechnology strength attributed to EMJ Capital long call


Sana Biotechnology initiated with an Outperform at Wedbush

2025-09-24T10:50:09.000Z - 8 months ago

Sana Biotechnology initiated with an Outperform at Wedbush


Sana Biotechnology reports Q2 EPS (16c), consensus (21c)

2025-08-11T20:55:26.000Z - 9 months ago

Sana Biotechnology reports Q2 EPS (16c), consensus (21c)


Why Is Sana Biotechnology Stock Down 25% Today?

2025-08-08T00:28:00.000Z - 9 months ago

Why Is Sana Biotechnology Stock Down 25% Today?


Sana Biotechnology 20.9M share Spot Secondary priced at $3.35

2025-08-07T10:37:28.000Z - 9 months ago

Sana Biotechnology 20.9M share Spot Secondary priced at $3.35


Sana Biotechnology Announces Pricing of Public Offering

Aug 6, 2025, 11:24 PM EDT - 9 months ago

Sana Biotechnology Announces Pricing of Public Offering


This Biotech Stock Just Soared 240%. Why It Can Go Higher.

Jan 8, 2025, 7:25 AM EST - 1 year ago

This Biotech Stock Just Soared 240%. Why It Can Go Higher.


Sana Biotechnology Transcript: Study Result

Jan 7, 2025, 4:30 PM EST - 1 year ago

Sana Biotechnology Transcript: Study Result


BriOnH
BriOnH May. 8 at 5:28 PM
$SANA Interview (video) with Steve Harr https://www.biopharminternational.com/view/stem-cell-derived-islet-therapies-target-type-1-diabetes-challenges
1 · Reply
Ornery
Ornery May. 8 at 3:36 PM
$SANA added another 1000 shares just because
0 · Reply
demarco4ever
demarco4ever May. 8 at 3:03 PM
$SANA I think we are at the new bottom ! Hopefully up from here
0 · Reply
MorganHoratio
MorganHoratio May. 8 at 1:44 PM
Google just released its updated 13F filing which shows all the stocks it owned as of the end of Q1: PayPay Corp (Tokyo-listed) - 3,125,000 $PL - 35,248,893 $PRME - 16,562,498 $RLAY - 1,564,173 $RVMD - 3,292,525 $SANA - 2,812,500 Google’s Q1 13F is here: Fintech, Real-time Earth, and Gene Editing! The 3.1M share stake in PayPay is a major power move into the East Asian payment ecosystem. Meanwhile, holding 35M shares of $PL (Planet Labs) signals that Google is weaponizing satellite data to give Gemini AI a "God’s eye view" of global logistics. Heavy bets on $PRME and $RVMD also prove that AI-driven oncology and gene editing are now core to Alphabet’s "Other Bets." Do you think the synergy between satellite data and fintech will lead to a breakthrough in 2026? Which of these strategic pivots are you most bullish on?
0 · Reply
LoveRetailFroth
LoveRetailFroth May. 8 at 1:11 PM
$AMLX Good Morning ☕️ $SMMT $SANA $RXRX
0 · Reply
BBraggHillBoys
BBraggHillBoys May. 7 at 9:53 PM
0 · Reply
LoveRetailFroth
LoveRetailFroth May. 7 at 12:55 PM
$SANA Perking up to Earnings Potential 10X☕️🚀
0 · Reply
LoveRetailFroth
LoveRetailFroth May. 7 at 12:51 PM
$SMMT Good Morning ☕️ Another $RVMD here. $AMLX $SANA $RXRX
0 · Reply
Love_To_Learn
Love_To_Learn May. 7 at 12:41 PM
$SANA $SLS $NA MOVING THE CHAINS
0 · Reply
OnlyInvestor
OnlyInvestor May. 7 at 6:45 AM
$SANA completely off topic but lots of diabetics in here. If you’re bored and day dreaming of cures, or thinking about your busted pancreas, Google “Human α-cell plasticity.” Some old medical journals about alpha cells spontaneously converting to beta cells (not enough to be effective) during autopsies of dead people. Crazy the things our bodies do to try and work around this BS
1 · Reply
ae81120
ae81120 May. 7 at 3:48 AM
0 · Reply
JerryMalone32
JerryMalone32 May. 6 at 4:35 PM
$SANA it has been 3 weeks since Mayo Clinic news. I think we are nearing news on IND for SC451 being cleared by FDA. Expecting that in May/June.
0 · Reply
LoveRetailFroth
LoveRetailFroth May. 6 at 1:14 PM
$SMMT Good Morning my bio 💎 s ☕️ $SANA $AMLX $TEM $RXRX
0 · Reply
BriOnH
BriOnH May. 5 at 8:17 PM
$SANA https://sana.gcs-web.com/news-releases/news-release-details/sana-biotechnology-present-bofa-securities-2026-healthcare
1 · Reply
Salehoz
Salehoz May. 5 at 6:33 PM
0 · Reply
GLPHOTOX
GLPHOTOX May. 5 at 2:52 PM
$SANA Run , Forrest Run!
0 · Reply
BillionerOfKing
BillionerOfKing May. 5 at 1:11 PM
$SANA Current Stock Price: $3.42 Contracts to trade: $2.5 SANA May 15 2026 Call Entry: $0.72 Exit: $1.06 ROI: 47% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
LoveRetailFroth
LoveRetailFroth May. 5 at 12:52 PM
$RXRX Good Morning ☕️ My Bio 💎 s $SMMT $SANA $TEM $AMLX
0 · Reply
Salehoz
Salehoz May. 4 at 2:46 PM
0 · Reply
LoveRetailFroth
LoveRetailFroth May. 4 at 1:40 PM
$SMMT Good Morning ☕️ Hope everyone added on Friday. I did, doubled my position. Future Lung Cancer therapy. This will be $100 plus in a yrs time$AMLX to $40, $SANA & $RXRX $10 plus. Have a great week!
0 · Reply
cta7978
cta7978 May. 4 at 2:20 AM
$FATE FATE trades at a depressed 0.86 P/B with BVPS ~$1.80 and stock ~$1.53. Peers $IPSC (2.5x P/B) and $SANA (~5.5x P/B) suggest a rerate to $4.50–$9.90/share (or higher) at similar multiples. FATE is further ahead clinically with Phase 1 FT819 CAR-T data in autoimmune (SLE etc.) showing meaningful responses, while IPSC and SANA remain mostly pre-IND or earlier in comparable programs. Strong data could easily justify a 4–7x+ P/B premium given the iPSC leadership and de-risking. High risk/high reward—watch the next readouts. DYOR.
1 · Reply
SKIJK
SKIJK May. 3 at 2:24 PM
$SANA Insider Monkey Wedbush Lifts PT on Sana Biotechnology (SANA) to $7 From $6
0 · Reply